Proteomic approach to investigate allergens involved in severe walnut allergy
Pediatric Allergy and Immunology · 2026
DOI: 10.1111/pai.70291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2026. Verfasst von Satoshi Mochizuki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kasugai Municipal Hospital, Kasugai, Japan. Hauptthemen laut MEDLINE: Juglans, Nut Hypersensitivity, Allergens. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Despite the increasing prevalence of walnut allergy (WA), no allergen components have been established as markers of disease severity. This study aimed to identify proteins specifically associated with severe WA in children.
Methods
We analyzed 48 children aged 3.4–16 years who underwent an oral food challenge to walnut between February 2019 and March 2022. Children with positive and negative reactions were categorized into a WA group and walnut sensitization (WS) group, respectively. The dose‐adjusted reaction severity of WA patients was quantified using the Anaphylaxis Scoring Aichi's total score divided by the cumulative protein dose that induced symptoms (TS/Pro). Using the median TS/Pro value in all cases of the WA group as a cut‐off, 11 of 21 WA patients with stored sera were classified as high TS/Pro (TS/Pro ≥154.1); the remaining 10 patients were classified as low TS/Pro. Immunoblotting, mass spectrometry, and enzyme‐linked immunosorbent assay (ELISA) were used to identify candidate markers of WA severity.
Results
Jug r 1‐specific IgE (sIgE) levels were higher in the WA group, but were not significantly associated with TS/Pro. Immunoblotting and mass spectrometry detected phospholipase D alpha 1 (PLDa1) in 5/11 (45.5%) high TS/Pro patients and 1/10 (10%) low TS/Pro patients ( p = .149). ELISA with recombinant PLDa1 confirmed similar results. Moreover, the absorbance of recombinant PLDa1‐sIgE was significantly correlated with TS/Pro ( ρ = 0.47, p = .032).
Conclusions
PLDa1 (Jug r 9) is a candidate marker of WA severity. The early identification of children at risk of severe WA may aid clinicians in optimizing their management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kasugai Municipal Hospital, Kasugai, Japan.
- Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Obu, Japan.
- Collaborative Department of Advanced Allergy and Immunology, Fujita Health University School of Medicine, Nagoya, Japan.
- General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan.
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.
ORCID-Profile: Satoshi Mochizuki, Naoshi Shimojo, Teruaki Matsui, Katsumasa Kitamura, Miki Sato, Shiro Sugiura, Yoshihiro Takasato, Masashi Nakamura, Kayoko Matsunaga, Akiko Yagami, Komei Ito
Zitieren
APA
Mochizuki, S., Shimojo, N., Matsui, T., Kitamura, K., Sato, M., Sugiura, S., Takasato, Y., Nakamura, M., Matsunaga, K., Yagami, A., & Ito, K. (2026). Proteomic approach to investigate allergens involved in severe walnut allergy. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70291
Vancouver
Mochizuki S, Shimojo N, Matsui T, Kitamura K, Sato M, Sugiura S, et al. Proteomic approach to investigate allergens involved in severe walnut allergy. Pediatric Allergy and Immunology. 2026. doi:10.1111/pai.70291
BibTeX
@article{Mochizuki2026,
author = {Mochizuki, Satoshi and Shimojo, Naoshi and Matsui, Teruaki and Kitamura, Katsumasa and Sato, Miki and Sugiura, Shiro and Takasato, Yoshihiro and Nakamura, Masashi and Matsunaga, Kayoko and Yagami, Akiko and Ito, Komei},
title = {Proteomic approach to investigate allergens involved in severe walnut allergy},
journal = {Pediatric Allergy and Immunology},
year = {2026},
doi = {10.1111/pai.70291}
}
EUVIMED